Tranexamic Acid Diminishes Laser-Induced Melanogenesis

Area of Science:

• Dermatology
• Molecular Biology
• Biochemistry

Background:

• Post-inflammatory hyperpigmentation (PIH) presents a significant clinical challenge.
• Tranexamic acid, an anti-fibrinolytic agent, shows promise for treating melasma and UV-induced PIH.
• The exact mechanism by which tranexamic acid inhibits melanogenesis requires further elucidation.

Purpose of the Study:

• To investigate the inhibitory effects of tranexamic acid on melanogenesis in mouse (melan-a) and human melanocytes.
• To clarify the molecular mechanisms underlying tranexamic acid's action on melanocytes.

Main Methods:

• Culturing melan-a and human melanocytes with fractional CO2 laser-treated keratinocyte-conditioned media.
• Assessing melanin content and tyrosinase activity in tranexamic acid-treated and untreated cells.
• Evaluating protein levels of tyrosinase, TRP-1, and TRP-2, and investigating signaling pathway molecules in melan-a cells.

Main Results:

• Tranexamic acid significantly reduced melanin content and tyrosinase activity in melanocytes.
• Protein levels of tyrosinase, TRP-1, and TRP-2 were decreased by tranexamic acid treatment.
• The observed inhibition of melanogenesis involved the extracellular signal-regulated kinase (ERK) signaling pathway and microphthalmia-associated transcription factor (MITF) degradation.

Conclusions:

• Tranexamic acid demonstrates potent inhibitory effects on melanogenesis.
• The findings suggest tranexamic acid's potential as an effective therapeutic agent for PIH.
• Further research into tranexamic acid's mechanism could lead to improved PIH treatments.